RVL Pharmaceuticals plc — Form D

RVL Pharmaceuticals plc of BRIDGEWATER, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-31. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2023-08-31
• Form: D
• Accession: 0001739426-23-000003
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $5.0M
• Amount sold: $5.0M
• Investors: 1
• Date of first sale: 2023-08-18
• Revenue range: Decline to Disclose
• SEC file number: 021-491138

Issuer

• Name: RVL Pharmaceuticals plc
• CIK: 0001739426
• Entity type: Other
• Jurisdiction: IRELAND
• Address: 400 CROSSING BOULEVARD, BRIDGEWATER, NJ, 08807
• Phone: 908-809-1300

Officers, directors & promoters (8)

More

• CIK 1739426 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search